Key Highlights

  • TOYO is pouring $357 million into a 1.5 GW heterojunction solar-cell plant near Houston, extending a rapid onshoring push that has driven revenue and profit sharply higher.
  • For the first quarter of 2026 (unaudited and unreviewed), the company reported revenue of $142.8 million, up 177% from $51.5 million a year earlier, and swung to net income of $28.4 million from a $3.7 million loss.
  • TOYO has demonstrated it can scale volume fast, turn a loss into double-digit margins, and win US supply agreements, all while 45X credits and domestic-content bonuses reward the very onshoring it is pursuing.

The Immediate Catalyst

On June 8, 2026, TOYO (NASDAQ:TOYO) Co., Ltd. said it would build a 1.5 gigawatt N-type heterojunction (HJT) solar-cell factory in the Houston metropolitan area, a roughly $357 million project co-located with the module assembly plant it already operates in Texas. Management framed the move as its formal entry into US cell manufacturing, closing a gap in an "integrated onshore supply chain from polysilicon to panels." Engineering, design and procurement are under way, with pilot production expected within about 20 months, implying a start around early 2028.

The company estimates roughly 400 direct manufacturing jobs plus about 1,200 regional supply-chain positions. The capital-raising followed quickly. On June 24, TOYO priced a $50 million registered direct offering at $11.00 per share, issuing roughly 4.5 million ordinary shares alongside warrants for up to 4.5 million more at $13.20, exercisable over five years, with Roth Capital Partners and H.C. Wainwright & Co. as placement agents. Proceeds are earmarked for the Texas cell facility.

Why the Development Matters

The announcement matters because it deepens a strategic pivot that has already reshaped TOYO's financial profile. US-made HJT cells would let the company sell domestic-content modules into an American market shaped by the Inflation Reduction Act's 45X credits and tariff walls, potentially widening margins and insulating it from import restrictions. Vertical integration from polysilicon to cell to module is the same playbook First Solar and Qcells have used to command premium pricing. For a company whose revenue was a fraction of this scale two years ago, controlling domestic cell supply could convert one-off tariff arbitrage into a durable, policy-supported franchise, if it can be financed and executed without diluting shareholders excessively or tripping US trade defenses.

Business and Market Context

TOYO is a Cayman Islands-incorporated, Japan-rooted solar manufacturer that reached Nasdaq in 2024 via a SPAC merger and files as a foreign private issuer. Its operating base has migrated toward geographies that serve the US market outside China. The company runs cell manufacturing in Hawassa, Ethiopia, and Vietnam, and module assembly in Texas, where the first gigawatt of a planned 2 GW line came online in October 2025. Ethiopian cell capacity has been substantially allocated to confirmed orders, while Vietnamese output has been redirected toward India and Taiwan.

In January 2026, TOYO secured a US polysilicon supply arrangement, an attempt to build a traceable, non-Chinese feedstock chain as Washington tightens rules on Chinese-origin wafers. The Texas cell plant is the capstone of that onshoring logic, moving TOYO from an assembler of imported cells toward a domestically integrated producer competing directly with US incumbents.

Financial Position

TOYO's recent numbers show the pivot working, at least for now. For the first quarter of 2026 (unaudited and unreviewed), the company reported revenue of $142.8 million, up 177% from $51.5 million a year earlier, and swung to net income of $28.4 million from a $3.7 million loss. Gross margin expanded to 33.5% from 9.3%, gross profit rose nearly 895% to $47.8 million, and diluted EPS reached $0.75 versus a $0.10 loss. Adjusted EBITDA was $48.3 million. Notably, first-quarter revenue alone approached the company's full-year 2025 sales of about $154.7 million, underscoring how quickly volumes have scaled.

Cash and restricted cash totaled $72.2 million at March 31, with $54.4 million in unrestricted cash. Management reaffirmed 2026 guidance of 5.5 to 5.8 GW of cell shipments, 1.0 to 1.3 GW of module shipments and adjusted net income of $90 million to $100 million. The gap between that cash balance and a $357 million project, however, signals meaningful future financing needs beyond the initial $50 million raise, whether through project debt, partnerships or additional equity.

The Bull Case

The bull case rests on momentum plus policy tailwinds. TOYO has demonstrated it can scale volume fast, turn a loss into double-digit margins, and win US supply agreements, all while 45X credits and domestic-content bonuses reward the very onshoring it is pursuing. A US cell plant would let it capture more of the value chain and price at a domestic premium. At mid-2026 levels the stock had risen roughly 398% over twelve months, and at least one third-party model flagged shares as materially undervalued relative to the expansion pipeline if execution holds. Reaffirmed guidance implying roughly $90 million to $100 million of adjusted net income lends the story tangible earnings support.

The Bear Case and Principal Risks

The risks are equally concrete. On May 13, 2026, the Alliance for American Solar Manufacturing and Trade, whose members include First Solar and Hanwha Qcells, filed an anti-dumping and countervailing-duty petition alleging that TOYO and another producer use Ethiopia as a platform to route Chinese wafers into the US and circumvent existing tariffs. An affirmative Commerce Department finding could impose duties on the very Ethiopian output funding today's growth, a direct threat to the earnings base.

Execution and financing risk compound this: a $357 million plant dwarfs current cash, so further dilution is likely, and the June offering already added shares plus warrants struck at $13.20. The equity itself is extraordinarily volatile, small-float and thin, with realized volatility cited near 130 versus about 32 for the market, so swings can be violent and disconnected from fundamentals. Unaudited quarterly figures add another layer of caution.

What Investors Should Watch Next

Watch the Commerce Department's decision on whether to initiate the Ethiopia circumvention investigation and any preliminary duty determinations, which could reprice the stock quickly. Track how TOYO funds the remaining Texas capital gap beyond the $50 million raise, including any project debt or strategic partner. Milestones on the Houston cell plant's construction and pilot timeline, second-quarter 2026 results against reaffirmed guidance, follow-through on the $185.6 million supply agreements, and progress qualifying its US polysilicon feedstock all bear close monitoring.

Conclusion

TOYO has turned an onshoring thesis into rapid revenue growth and its first sustained profits, and the Texas HJT plant would, if built and financed on plan, cement a US-integrated position that policy actively rewards. Yet the same trade barriers that create its opportunity now point back at its Ethiopian supply base through a live circumvention case, and a project many times larger than its cash balance guarantees more financing. The result is a high-conviction growth story wrapped in unusually high policy, execution and volatility risk, one where the next several quarters of trade rulings and construction milestones will matter far more than the headline capex figure.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.